keyword
MENU ▼
Read by QxMD icon Read
search

perceval Valve

keyword
https://read.qxmd.com/read/30777843/transcatheter-aortic-valve-in-valve-implantation-in-degenerative-rapid-deployment-surgical-bioprosthesis
#1
Uri Landes, Danny Dvir, Wolfgang Schoels, Christopher Tron, Stephan Ensminger, Matheus Simonato, Ulrich Schäfer, Matjaz Bunc, Gabriel Aldea, Alfredo Cerillo, Stephan Windecker, Antonio Marzocchi, Martin Andreas, Nicolas Amabile, John Webb, Ran Kornowski
AIMS: To evaluate transcatheter aortic valve-in-valve implantation performance in rapid deployment (ViVr) vs. conventional (ViVc) surgical heart valve (SHV). METHODS AND RESULTS: A multicenter registry was developed as part of the VIVID international registry. A total of 30 ViVr [Perceval (Sorin Biomedica, Salugia, Italy), n=24, the ATS 3F Enable (Medtronic Inc., Minneapolis, MN, USA), n=5, and the Intuity (Edwards Lifesciences, Irvine, CA, USA), n=1] were evaluated and compared with 2,288 ViVc patients...
February 19, 2019: EuroIntervention
https://read.qxmd.com/read/30689828/operative-outcome-of-patients-at-low-intermediate-high-and-very-high-surgical-risk-undergoing-isolated-aortic-valve-replacement-with-sutureless-and-rapid-deployment-prostheses-results-of-the-surd-ir-registry
#2
Giuseppe Santarpino, Paolo Berretta, Theodor Fischlein, Thierry P Carrel, Kevin Teoh, Martin Misfeld, Carlo Savini, Utz Kappert, Mattia Glauber, Emmanuel Villa, Bart Meuris, Carmelo Mignosa, Alberto Albertini, Gianluca Martinelli, Thierry A Folliguet, Malak Shrestha, Marco Solinas, Günther Laufer, Kevin Phan, Tristan Yan, Marco Di Eusanio
OBJECTIVES: The ideal strategy for the treatment of severe aortic valve stenosis in patients of varying risk categories has become a debated topic in the last years: should the transcatheter or surgical approach be adopted? The aim of this study was to evaluate the outcomes of low-, intermediate-, high- and very high-risk patients undergoing sutureless, rapid deployment aortic valve replacement. METHODS: From 2007 to 2017, data on a total of 3651 patients were collected from the Sutureless and Rapid Deployment Aortic Valve Replacement International Registry (SURD-IR)...
January 25, 2019: European Journal of Cardio-thoracic Surgery
https://read.qxmd.com/read/30684479/sutureless-aortic-valve-and-pacemaker-rate-from-surgical-tricks-to-clinical-outcomes
#3
Ferdinand Vogt, Marco Moscarelli, Anna Nicoletti, Renato Gregorini, Francesco Pollari, Jurji M Kalisnik, Steffen Pfeiffer, Theodor Fischlein, Giuseppe Santarpino
BACKGROUND: Several studies reported high rates of postoperative permanent pacemaker (PPM) implantation, which has been described as the "Achilles' heel" of sutureless aortic valve replacement (AVR). METHODS: From July 2010 to December 2017, 3158 patients with symptomatic, severe aortic valve stenosis were referred to our cardiac surgery center and 512 received a Perceval sutureless bioprosthesis. Thirty-nine patients who had been discharged with concomitant PPM implantation were re-evaluated...
January 23, 2019: Annals of Thoracic Surgery
https://read.qxmd.com/read/30669172/clinical-short-term-outcome-and-hemodynamic-comparison-of-six-contemporary-bovine-aortic-valve-prostheses
#4
Martin Hartrumpf, Ralf-Uwe Kuehnel, Filip Schroeter, Robert Haase, Magdalena L Laux, Roya Ostovar, Johannes M Albes
BACKGROUND:  Conventional stented valves (CV) remain gold standard for aortic valve disease. Bovine prostheses have been improved and rapid deployment valves (RDV) have arrived in the recent decade. We compare clinical and hemodynamic short-term outcome of six bovine valves. METHODS:  We retrospectively evaluated 829 consecutive patients (all-comers) receiving bovine aortic valve replacement (AVR). Four CV from different manufacturers (Mitroflow, Crown, Perimount, Trifecta) and two RDV (Perceval, Intuity) were compared in terms of pre-, intra-, and postprocedural data...
January 22, 2019: Thoracic and Cardiovascular Surgeon
https://read.qxmd.com/read/30560612/double-valve-failure-due-to-perceval-sutureless-aortic-valve-migration
#5
Michele Rossi, Lucia Cristodoro, Devotini Roger, Virgilio Pennisi, Giuseppe Pisano, Pasquale Fratto
A 76-year-old woman was admitted to the authors' hospital with pulmonary edema five months after the successful implantation of a Perceval sutureless aortic valve (Sorin Group Srl, Saluggia, Italy). Both echocardiography and computed tomography scanning demonstrated migration of the aortic valve into the left ventricle, causing severe aortic and mitral (secondary) insufficiency. Following heart team discussions, the sutureless valve was replaced with a standard bioprosthesis (Perimount, Magna Ease; Edwards Lifesciences, Irvine, California, USA) with spontaneous restoration of native mitral valve competence...
January 2018: Journal of Heart Valve Disease
https://read.qxmd.com/read/30553598/prospective-us-investigational-device-exemption-trial-of-a-sutureless-aortic-bioprosthesis-one-year-outcomes
#6
Rakesh M Suri, Hoda Javadikasgari, David A Heimansohn, Neil J Weissman, Gorav Ailawadi, Niv Ad, Gabriel S Aldea, Vinod H Thourani, Wilson Y Szeto, Robert E Michler, Hector I Michelena, Reza Dabir, Gregory P Fontana, William F Kessler, Michael G Moront, Louis A Brunsting, Bartley P Griffith, Alvaro Montoya, Sreekumar Subramanian, Mark A Mostovych, Eric E Roselli
OBJECTIVES: We performed a prospective, single-arm clinical trial approved under a Food and Drug Administration Investigational Device Exemption to assess safety and efficacy of Perceval, a sutureless bovine pericardial aortic valve representing the initial US experience. METHODS: From June 2013 to January 2015, 300 patients (mean age 76.7 ± 7.7 years, 54.3% men, 37.3% ≥80 years, median Society of Thoracic Surgeons Predicted Risk of Mortality 2.8%), underwent Perceval valve implantation at 18 centers across the United States...
October 23, 2018: Journal of Thoracic and Cardiovascular Surgery
https://read.qxmd.com/read/30497085/sutureless-versus-stented-bioprostheses-for-aortic-valve-replacement-the-randomized-persist-avr-study-design
#7
Roberto Lorusso, Thierry Folliguet, Malakh Shrestha, Bart Meuris, Arie Pieter Kappetein, Eric Roselli, Catherine Klersy, Michele Nozza, Luc Verhees, Cristina Larracas, Giovanni Goisis, Theodor Fischlein
INTRODUCTION:  Sutureless biological valves for surgical aortic valve replacement (SAVR), characterized by the absence of anchoring sutures at the aortic annulus, are gaining popularity because of ease and reproducibility of implant, shorter operating times, and enhancement of minimally invasive approaches. The stentless configuration of the sutureless valve was designed to achieve optimal hemodynamic performance. MATERIALS AND METHODS:  PERSIST-AVR (PERceval Sutureless Implant versus STandard Aortic Valve Replacement) is a prospective, randomized, adaptive, open-label, international, postmarket trial (NCT02673697)...
November 29, 2018: Thoracic and Cardiovascular Surgeon
https://read.qxmd.com/read/30367839/perceval-valve-implantation-technical-details-and-echocardiographic-assessment
#8
Vishnu Vasanthan, William Kent, Alexander Gregory, Andrew Maitland, Charles Cutrara, Denis Bouchard, Federico Asch, Corey Adams
The Perceval valve (LivaNova, London, United Kingdom) is a collapsible, sutureless bioprosthetic aortic valve. This novel design is well suited for minimally invasive approaches and has particular advantages for patients with small, calcified annuli. The implantation technique is unique and echocardiographic assessment of valve cage shape, angulation and height are essential. The following discussion provides a framework of technical and sonographic considerations to help surgical teams achieve reproducible success with Perceval valve deployment...
October 24, 2018: Annals of Thoracic Surgery
https://read.qxmd.com/read/30348270/sutureless-aortic-bioprosthesis-replacement-in-elderly-asian-patients-with-aortic-stenosis-experience-in-a-single-institution
#9
Chun-Yu Lin, Hsiu-An Lee, Pyng-Jing Lin, Chun-Li Wang, Kuo-Chun Hung, Feng-Chun Tsai
BACKGROUND: Sutureless aortic valve replacement (SU-AVR) has emerged as a promising alternative for the treatment of patients with aortic valve stenosis. This study aims to assess the safety and efficacy of SU-AVR in an elderly Asian population. METHODS: From June 2015 to May 2016, 15 adults with severe aortic stenosis (9 females) with a median age of 79 years underwent Perceval sutureless bioprosthesis (LivaNova, UK) implantation in a single Taiwanese institution; peri-operative recovery, clinical improvement, and valve performance were analyzed...
August 2018: Biomedical Journal
https://read.qxmd.com/read/30344959/snugger-method-the-oldenburg-modification-of-perceval-implantation-technique
#10
Ahmed Mashhour, Konstantin Zhigalov, Marcin Szczechowicz, Sabreen Mkalaluh, Jerry Easo, Harald Eichstaedt, Dmitry Borodin, Jürgen Ennker, Alexander Weymann
We present a modified implantation technique of the Perceval® sutureless aortic valve (LivaNova, London, United Kingdom) that involves the usage of snuggers for the guiding sutures during valve deployment. Both limbs of each guiding suture are pulled through an elastic tube, which is fixed with a Pean clamp, which tightens the sutures and fixes the prosthesis to the aortic annulus during valve deployment. This method proved safe and useful in over 120 cases. Valve implantation was facilitated and the need for manipulation by the assistant or the nurse was eliminated...
September 26, 2018: World Journal of Cardiology
https://read.qxmd.com/read/30321588/sutureless-valve-replacement-through-a-right-anterior-mini-thoracotomy-in-elderly-patients-with-stenotic-bicuspid-aortic-valve
#11
Mustafa Serkan Durdu, Fatih Gumus, Evren Ozcinar, Mehmet Cakici, Onat Bermede, Irem Dincer, Mustafa Kılıckap, Mustafa Sirlak, Kemalettin Ucanok, Ahmet Ruchan Akar
OBJECTIVE: Several indications for sutureless aortic valve replacement (SU-AVR) have been a matter of debate. We evaluated our experience with Perceval-S® (LivaNova group, Saluggia, Italy) SU-AVR in patients with severe aortic stenosis (AS) involving bicuspid aortic valve (BAV), even though presence of BAV is still considered to be a contraindication for sutureless valves. METHODS: From January 2013 through March 2018, thirteen patients with severe aortic stenosis involving BAV underwent SU-AVR with the Perceval-S® (LivaNova group, Saluggia, Italy) prosthesis in a single center...
October 12, 2018: Seminars in Thoracic and Cardiovascular Surgery
https://read.qxmd.com/read/30234906/sutureless-aortic-valve-replacement-in-high-risk-patients-neutralizes-expected-worse-hospital-outcome-a-clinical-and-economic-analysis
#12
Emmanuel Villa, Margherita Dalla Tomba, Antonio Messina, Andrea Trenta, Federico Brunelli, Marco Cirillo, Zean Mhagna, Giovanni Alfonso Chiariello, Giovanni Troise
BACKGROUND: Aortic valve replacement (AVR) by sutureless prostheses is changing surgeon options, although which patients benefit most, as well as their possible economic impact is still to be defined. METHODS: Perceval-S prosthesis (LivaNova) is reserved, at the documented Institution, for patients at perceived high surgical risk. This retrospective analysis of outcome and resource consumption compared Perceval with other tissue valves. To clarify the comparison, only patients respecting 'instructions-for-use' of Perceval were reviewed...
September 20, 2018: Cardiology Journal
https://read.qxmd.com/read/30180979/implantation-of-perceval-valve-in-mitral-position-a-new-technique
#13
Marcin Szczechowicz, Ahmed Mashhour, Onise Chaduneli, Alexander Weymann
No abstract text is available yet for this article.
August 2, 2018: Journal of Thoracic and Cardiovascular Surgery
https://read.qxmd.com/read/29963376/ten-year-experience-with-the-perceval-s-sutureless-prosthesis-lessons-learned-and-future-perspectives
#14
REVIEW
Vincent Chauvette, Amine Mazine, Denis Bouchard
Aortic stenosis has traditionally been addressed with surgical aortic valve replacement (AVR). In recent years, several technologies have emerged as alternative treatment methods for aortic valve disease. Among them, the Perceval (LivaNova, London, UK) is a sutureless valve that has been used in clinical practice for over 10 years. It has been implanted in over 20,000 patients worldwide. With nearly 600 Perceval implants since 2011, the Montreal Heart Institute has developed a worldwide expertise with this technology...
2018: Journal of Visualized Surgery
https://read.qxmd.com/read/29898147/thrombocytopenia-after-aortic-valve-replacement-comparison-between-sutureless-perceval-s-valve-and-perimount-magna-ease-bioprosthesis
#15
Syed Saleem Mujtaba, Simon Ledingham, Asif Raza Shah, Stephan Schueler, Stephen Clark, Thasee Pillay
INTRODUCTION: The incidence of postoperative thrombocytopenia after aortic valve replacement (AVR) with the Perceval S Sutureless bioprosthesis remains unclear. The aim of this study was to report thrombocytopenia associated with the use of sutureless AVR. METHODS: The data was collected retrospectively for patients who had isolated AVR with sutureless Perceval S valve (Group A: 72 patients) and was compared with patients who underwent isolated sutured AVR with Perimount Magna Ease Bioprosthesis (Group B: 101 patients) in our institution between June 2014 and January 2017...
March 2018: Brazilian Journal of Cardiovascular Surgery
https://read.qxmd.com/read/29898140/aortic-valve-replacement-with-a-conventional-stented-bioprosthesis-versus-sutureless-bioprosthesis-a-study-of-763-patients
#16
Syed Saleem Mujtaba, Simon M Ledingham, Asif Raza Shah, Thasee Pillay, Stephan Schueler, Stephen Clark
OBJECTIVE: The aim of this retrospective study was to compare early postoperative outcomes after aortic valve replacement (AVR) with sutureless bioprostheses and conventional stented bioprostheses implanted through median sternotomy. METHODS: From January 2011 to December 2016, 763 patients underwent aortic valve replacement with bioprostheses; of these, 139 received a Perceval S sutureless valve (Group A) and 624 received a Perimount Magna Ease valve (Group B)...
March 2018: Brazilian Journal of Cardiovascular Surgery
https://read.qxmd.com/read/29866522/early-outcomes-of-sutureless-aortic-valve-replacement-with-the-perceval-s-bioprosthesis
#17
Michael Kosasih, Aubrey A Almeida, Julian A Smith
BACKGROUND: Sutureless aortic valve replacement (SU-AVR) offers an alternative to traditional aortic valve replacement (AVR) and is becoming widely performed in many hospitals. The aim of the current study was to evaluate the early experience in SU-AVR with the Perceval S bioprosthesis at Monash Medical Centre. METHODS: Fifty-two patients who underwent SU-AVR were retrospectively analysed (mean age: 74.8±6.5years). Data regarding preoperative and operative details, hospital stay, postoperative outcomes within 30days after surgery, re-admissions and longer term echocardiographic data were collected from the relevant hospital databases...
May 18, 2018: Heart, Lung & Circulation
https://read.qxmd.com/read/29804686/transesophageal-echocardiographic-assessment-of-the-sutureless-perceval-aortic-valve
#18
REVIEW
Adam A Dalia, Caroline Hunter, Elliot Woodward, David Dudzinski, Michael Andritsos, Michael Essandoh, Michael Andrawes
No abstract text is available yet for this article.
April 26, 2018: Journal of Cardiothoracic and Vascular Anesthesia
https://read.qxmd.com/read/29788476/the-flutter-by-effect-a-comprehensive-study-of-the-fluttering-cusps-of-the-perceval-heart-valve-prosthesis
#19
Ali Aljalloud, Mohamed Shoaib, Sandrine Egron, Jessica Arias, Lachmandath Tewarie, Heike Schnoering, Shahram Lotfi, Andreas Goetzenich, Nima Hatam, Desiree Pott, Zhaoyang Zhong, Ulrich Steinseifer, Rachad Zayat, Ruediger Autschbach
OBJECTIVES: Sutureless aortic valve prostheses are gaining popularity due to the substantial reduction in cross-clamp time. In this study, we report our observations on the cusp-fluttering phenomenon of the Perceval bioprosthesis (LivaNova, London, UK) using a combination of technical and medical perspectives. METHODS: Between August 2014 and December 2016, a total of 108 patients (69% women) with a mean age of 78 years had aortic valve replacement using the Perceval bioprosthesis (34 combined procedures)...
November 1, 2018: Interactive Cardiovascular and Thoracic Surgery
https://read.qxmd.com/read/29701355/aortic-valve-replacement-with-perceval%C3%A2-bioprosthesis-initial-single-center-experience
#20
Diogo Rijo, Sara Simões Costa, João Pedro Monteiro, Fátima Neves, Luís Vouga, Paulo Neves, Paulo Ponce, Miguel Guerra
INTRODUCTION: Aortic valve replacement (AVR) is the gold standard for the treatment of severe or symptomatic aortic valve stenosis. Less invasive procedures have been developed as an alternative to the conventional technique of full sternotomy approach with stented prosthesis. The Perceval® aortic valve (LivaNova, Milan, Italy) is a sutureless bioprosthesis, of which several reports have shown promising results in terms of mortality, morbidity and hemodynamic performance, especially with a less invasive approach...
July 2017: Revista Portuguesa de Cirurgia Cardio-torácica e Vascular
keyword
keyword
109194
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"